Stroke Journal
JANUARY 30, 2025
We conducted internal validation on the same samples using the PeptiQuant Plus biomarker assessment kits (BAK-270) for targeted protein quantitation (Figure 1).Results:We Blood samples were collected at admission to the ER before any therapeutic intervention. Results:We included 100 patients (mean age 58.6
Stroke Journal
JANUARY 30, 2025
4.94), but not with 90-day mRS or mortality.Conclusion:Serum creatinine-based biomarkers of renal dysfunction were associated with faster progressor phenotype of ACLVO stroke, higher mRS, and mortality at 90 days. Patients were included if they received baseline MRI or CTP on presentation within 24 hours after stroke onset.
Stroke Journal
JANUARY 30, 2025
Conclusions:Our discovery proteomics study highlights the potential of DIA-MS proteomics as a valuable tool for discovering novel protein biomarkers to distinguish TIA from MIM. While TIA patients are at an increased risk of stroke, MIM do not need stroke-related management. These findings warrant validation in larger, longitudinal studies.
Open Heart
APRIL 11, 2022
Biomarkers for iron stores (serum ferritin and serum transferrin receptor) was analysed from frozen blood samples in 2014. All hospital admissions were registered through national registers during the entire follow-up from 1993 to 2014. HRs were estimated by Cox proportional-hazard regression analyses.
Frontiers in Cardiovascular Medicine
JANUARY 19, 2025
This study investigates the interrelationship between hypoxic liver injury (HLI) and Killip classification.Method and resultsA total of 1,537 STEMI patients who underwent percutaneous coronary intervention (PCI) from 2007 to 2014 at four tertiary hospitals in the Incheon-Bucheon province were enrolled in this study.
Open Heart
JUNE 24, 2022
on cardiac troponin I, a cardiomyocyte specific biomarker of cellular damage. Troponin I measurements were available from 2014 to 2016, and were required to be at least 1 week away from a clinically diagnosed MI. Here we evaluate the impact of daily PM 2.5
Dr. Smith's ECG Blog
APRIL 18, 2024
1] European guidelines add "regardless of biomarkers". 2014 AHA/ACC guideline for the management of patients with non-ST elevation acute coronary syndromes. Circulation 2014 2. But only 6.4% of such ‘high risk Non-STEMI’ patients get angiography within 2 hours.[2] It is not yet available, but this is your way to get on the list.
Expert insights. Personalized for you.
40 
Let's personalize your content